Hamamah S

No ORCID on file · 12 papers in corpus
other 2026
PharmacoEconomics - open ·doi:10.1007/s41669-026-00641-2

BACKGROUND: Follitropin delta, using a personalized dosing regimen, is an effective treatment option for women undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). OBJECT…

review 2026
International journal of molecular sciences ·doi:10.3390/ijms27177766

Human fertility is declining across industrialised populations, while the incidence of hormone-dependent reproductive cancers rises. Endocrine-disrupting chemicals (EDCs) and structurally related emerging pollutants are implicated in both. …

review 2025
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2025.104957

Couple infertility poses a health challenge, prompting research into its multifaceted aetiology. Non-coding RNA (ncRNA) expression has emerged as a candidate for elucidating couple infertility. This review explores the roles of small and lo…

review 2024
International journal of molecular sciences ·doi:10.3390/ijms252211981

Infertility, defined as the inability to obtain pregnancy after 12 months of regular unprotected sexual intercourse, has increased in prevalence over the past decades, similarly to chronic, allergic, autoimmune, or neurodegenerative disease…

observational 2023
International journal of environmental research and public health ·doi:10.3390/ijerph20032542

OBJECTIVE: Diethylstilbestrol (DES), a potent synthetic nonsteroidal estrogen belonging to the family of endocrine disrupting chemicals (EDCs), can cross the placenta and may cause permanent adverse health effects in the exposed mothers, th…

meta-analysis 2021
International journal of molecular sciences ·doi:10.3390/ijms22169091

Previous studies have demonstrated that endocrine disruptors (EDs) can promote the transgenerational inheritance of disease susceptibility. Among the many existing EDs, 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD) affects reproductive health, …

case-report 2021
Environmental health : a global access science source ·doi:10.1186/s12940-021-00780-5

BACKGROUND: Endometriosis, which affects 10-15 % of women of reproductive age, is an estrogen-driven condition influenced by environmental and genetic factors. Exposition to estrogen-like endocrine-disrupting chemicals (EDCs) has been repor…

case-report 2021
International journal of environmental research and public health ·doi:10.3390/ijerph18199965

BACKGROUND: Psychiatric disorders in children exposed in utero to diethylstilbestrol (DES) are still debated. We report here the impact of DES prescribed to suppress lactation on the children born after such treatment and their progeny, foc…

review 2011
Human Reproduction Update ·doi:10.1093/humupd/dmr033

BACKGROUND: The Fifth Evian Annual Reproduction (EVAR) Workshop Meeting discussed knowledge regarding contemporary genetics in female reproduction. METHODS: Specialist reproductive medicine clinicians and geneticists delivered presentation…

observational 2010
Gynecologie, obstetrique & fertilite ·doi:10.1016/j.gyobfe.2010.08.018

OBJECTIVE: To evaluate fertility outcomes after laparoscopic and ART management of endometriosis in an infertile population. PATIENTS AND METHODS: Retrospective analysis including 79 infertile patients treated by laparoscopic surgery. Fert…

review 2009
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513590903159599

This review aims to evaluate whether severe endometriosis has an impact on the outcome of in vitro fertilisation (IVF), whether IVF is associated with specific complications in this context, whether a specific ovarian stimulation protocol i…

rct 1998
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(98)00028-1

OBJECTIVES: To determine the effectiveness of a 6-month course of nafarelin in the treatment of stage III-IV endometriosis and to determine if pre-operative use of nafarelin facilitates surgery. DESIGN: Prospective, multicenter, clinical t…